We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich Orange Fluorescent Plga Nanopart. 500Nm&
List Price
$664.00
Your Price
$664.00
Sigma-Aldrich Orange Fluorescent Plga Nanopart. 500Nm& - SIALUPENN (Additional S&H or Hazmat Fees May Apply)
NETA PART:
SIALUPENN-942480-50MG
MFG.PART:
942480-50MG
UNSPSC:
41105331
Manufacturer:
Sigma-Aldrich
form
powder
Quality Level
100
mol wt
Mw 30000 Da
average diameter
500 nm
density
1.3 g/cm3
fluorescence
λex 530 nm; λem 582 nm (orange)
storage temp.
−20°C
Looking for similar products? Visit Product Comparison Guide
Related Categories
Biomedical Materials
Drug Delivery Formulations and Technologies
General description
PLGA (poly(lactic-co-glycolic acid)) is a biodegradable and biocompatible polymer, FDA-approved for biomedical applications. Upon administration, the PLGA polymer degrades through hydrolysis of its ester backbone into non-toxic byproducts. For drug-loaded particles, the drug molecules are gradually released, and this release rate can be fine-tuned by selecting different types of PLGA and adjusting the encapsulation process.
Factors that influence the degradation and drug release rates include:
Factors that influence the degradation and drug release rates include:
- Lactide to glycolide (L/G) ratio: a 50:50 L/G ratio exhibits the fastest drug release
- Molecular weight: Higher molecular weights result in slower release
- Terminal groups: Carboxyl-terminated PLGA polymer provide quicker release compared to ester-terminated PLGA
Application
Degradex® Orange Fluorescent PLGA nanoparticles are ideal for a wide range of biomedical and pharmaceutical R&D applications, including:
- Controlled drug release: The gradual degradation of PLGA allows for sustained release of encapsulated drug molecules, improving therapeutic efficacy and reducing dosing frequency.
- Bioavailability enhancement: PLGA nanoparticles can improve the solubility and stability of poorly water-soluble drugs, enhancing their bioavailability.
- Drug targeting: The nanoparticle structure enables targeted drug delivery to specific tissues or cells, potentially reducing side effects and improving treatment outcomes.
- API stabilization: Encapsulation in PLGA nanoparticles can protect sensitive active pharmaceutical ingredients (APIs) from degradation.
- Drug attachment and delivery: The nanoparticles can act as carriers, allowing drug molecules to be attached to their surface for efficient delivery.
- Imaging and cell tracking: Fluorescent nanoparticles can be utilized for imaging, fluid tracing, cell tracking, phagocytosis studies, and fluorescence microscopy. They are particularly effective in drug delivery applications and diagnostic R&D, particularly for detecting binding events or enhancing signals.
Features and Benefits
Degradex Orange Fluorescent PLGA nanoparticles are made with poly(D,L-lactide-co-glycolide) with an L/G ratio of 50/50 and a MW of 30,000.
Key Features:
Average diameter: 500nm +/- 100nm
Standard deviation: <50%
Fluorescence: Orange
Excitation/Emission: 530/582 nm
Packaged as a lyophilized powder, Degradex nanoparticles are designed to be reconstituted in an aqueous medium, such as deionized water or buffer, for common applications. It is crucial to ensure the particles are well suspended as a single-particle suspension without aggregation before use.
Reconstitution Instructions:
Key Features:
Average diameter: 500nm +/- 100nm
Standard deviation: <50%
Fluorescence: Orange
Excitation/Emission: 530/582 nm
Packaged as a lyophilized powder, Degradex nanoparticles are designed to be reconstituted in an aqueous medium, such as deionized water or buffer, for common applications. It is crucial to ensure the particles are well suspended as a single-particle suspension without aggregation before use.
Reconstitution Instructions:
- Remove the product from the freezer.
- Allow it to reach ambient temperature.
- Add deionized water or buffer to the container.
- Gently mix the contents to ensure the particles are well suspended; vortexing or sonication may be necessary.
Legal Information
Product of Phosphorex, Inc.
Degradex is a registered trademark of Phosphorex, Inc.
| SKU | SIALUPENN-942480-50MG |
|---|---|
| Supplier Part Number | 942480-50MG |
| UM | EA |
| UNSPSC | 41105331 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIALUPENN |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 9 |
| Energy Star | No |
| Green | No |
| Controlled | N |